Activation of Platelet Caspase‐1 and P‐Selectin Over‐Expression in Sickle Cell Disease Patients: An Involvement of NLRP3 Inflammasome?
Journal of Cellular and Molecular Medicine · 2026-10 · 30 (20)
DOI: 10.1111/jcmm.71390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 14.10.2026. Verfasst von Livia Claude und 8 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, BIGR, Université Paris Cité and Université des Antilles, Paris, France. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Blood Platelets, Caspase 1, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Hospital of Guadeloupe.
Abstract (Originalsprache)
Sickle cell disease (SCD) is characterized by hemolytic anaemia, painful vaso‐occlusive crises, and chronic inflammation resulting partly from platelet activation. It has been shown that platelets express the nucleotide‐binding domain leucine‐rich repeat containing protein 3 (NLRP3) and the apoptosis‐associated speck‐like protein containing a CARD (ASC), forming the NLRP3 inflammasome, which controls activation of caspase‐1 and cleavage of interleukin‐1β (IL‐1β). Bruton tyrosine kinase (BTK), known to activate the NLRP3 inflammasome, is also expressed in platelets. In SCD, platelets are activated and can secrete increased quantities of IL‐1β, suggesting a possible activation of the NLRP3 inflammasome. Here, we assessed platelet P‐selectin expression, caspase‐1 activation, platelet–neutrophil aggregate formations by flow cytometry and BTK phosphorylation by Western blot in a cohort of 81 adult SCD patients at steady state condition (34 SC and 47 SS patients). We showed an increase in platelet activation in sickle patients and a high level of platelet–neutrophil aggregate in SS patients compared to healthy subjects (17 AA). We also demonstrated platelet caspase‐1 activation in SCD patients and obtained data suggesting for the first time NLRP3 inflammasome activation in SC patients. Further studies are needed to understand the mechanism of caspase‐1 activation and evaluate the potential therapeutic efficiency of Ibrutinib, a BTK inhibitor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM, BIGR, Université Paris Cité and Université des Antilles, Paris, France.
- Laboratoire d'Hématologie, CHU de la Guadeloupe, Pointe-à-Pitre, Guadeloupe.
- Service de Réanimation, CHU de la Guadeloupe, Pointe-à-Pitre, Guadeloupe.
- Unité Transversale de la Drépanocytose, CHU de la Guadeloupe, Hôpital Ricou, Pointe-à-Pitre, Guadeloupe.
- Centre d'Investigation Clinique Antilles Guyane, Inserm CIC 1424, CHU de la Guadeloupe, Pointe-à-Pitre, Guadeloupe.
ORCID-Profile: Livia Claude, Frédéric Martino, Emmanuelle Bernit, Maryse Etienne-Julan, Benoît Tressières, Marc Romana, Véronique Baccini
Förderung
- University Hospital of Guadeloupe
Zitieren
APA
Claude, L., Martino, F., Mordier, L., Célanie, D., Bernit, E., Etienne-Julan, M., Tressières, B., Romana, M., & Baccini, V. (2026). Activation of Platelet Caspase‐1 and P‐Selectin Over‐Expression in Sickle Cell Disease Patients: An Involvement of NLRP3 Inflammasome?. Journal of Cellular and Molecular Medicine, 30(20). https://doi.org/10.1111/jcmm.71390
Vancouver
Claude L, Martino F, Mordier L, Célanie D, Bernit E, Etienne-Julan M, et al. Activation of Platelet Caspase‐1 and P‐Selectin Over‐Expression in Sickle Cell Disease Patients: An Involvement of NLRP3 Inflammasome?. Journal of Cellular and Molecular Medicine. 2026;30(20). doi:10.1111/jcmm.71390
BibTeX
@article{Claude2026,
author = {Claude, Livia and Martino, Frédéric and Mordier, Lydiane and Célanie, Doris and Bernit, Emmanuelle and Etienne-Julan, Maryse and Tressières, Benoît and Romana, Marc and Baccini, Véronique},
title = {Activation of Platelet Caspase‐1 and P‐Selectin Over‐Expression in Sickle Cell Disease Patients: An Involvement of NLRP3 Inflammasome?},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {20},
doi = {10.1111/jcmm.71390}
}
EUVIMED